Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase 2/3 1

Status

Completed 2Recruiting 1

Sponsor Class

OTHER 52INDUSTRY 45OTHER_GOV 3NIH 2NETWORK 1INDIV 1FED 1

Study Type

Interventional 3

Sponsor

Conditions

Breast Neoplasms 196Neoplasms 104Colorectal Neoplasms 91Stomach Neoplasms 80Uterine Cervical Neoplasms 70Carcinoma, Non-Small-Cell Lung 67Carcinoma, Hepatocellular 53Lung Neoplasms 48Prostatic Neoplasms 47Rectal Neoplasms 46Esophageal Neoplasms 39Pancreatic Neoplasms 37Colonic Neoplasms 36Ovarian Neoplasms 35Recurrence 33Head and Neck Neoplasms 33Neoplasm Metastasis 28Motor Activity 28Multiple Myeloma 27Small Cell Lung Carcinoma 26Melanoma 25Polycystic Ovary Syndrome 24Lymphoma, Non-Hodgkin 24Lymphoma 24Leukemia, Myeloid, Acute 21Precursor Cell Lymphoblastic Leukemia-Lymphoma 20Pain 20Brain Neoplasms 20Nasopharyngeal Carcinoma 18Hematologic Neoplasms 17

Interventions

human papillomavirus vaccine, L1 type 16, 18 1Tuberculin 1PRA1 protein, Candida albicans 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
OTHER_GOV × Interventional × Warts × Clear all
NCT05291845 2025-06-12

Candida Antigen and Bivalent HPV Vaccine in the Treatment of Multiple Warts

Zagazig University

Phase 2 Recruiting
162 enrolled

Warts

NCT05254561 2022-02-24

Triple Antigen vs Monoantigen Immunotherapy for Warts

Zagazig University

Phase 2/3 Completed
160 enrolled

Warts

NCT04399577 2020-05-27

Complement Component 3c and Tumor Necrosis Factor-α in Patients With Human Papillomavirus-Induced Cutaneous Warts

Zagazig University

Phase 2 Completed
39 enrolled

Warts

Data powered by HemOnc (CC BY 4.0) Colophon âš¡